A randomized, single-blind, comparison of duloxetine with bupropion in the treatment of SSRI-resistant major depression
INTRODUCTION: For patients who continue to experience depressive symptoms despite an
adequate antidepressant SSRI trial, across-class switch is considered one of the best …
adequate antidepressant SSRI trial, across-class switch is considered one of the best …
Quality of treatment and disability compensation in depression: comparison of 2 nationally representative samples with a 10-year interval in Finland.
TI Honkonen, TA Aro, ET Isometsa… - Journal of Clinical …, 2007 - psychiatrist.com
Objective: Depressive disorders cause substantial work impairment that can lead to
disability compensation. The authors compared treatment received for depression preceding …
disability compensation. The authors compared treatment received for depression preceding …
Safety and tolerability of adjunctive aripiprazole in major depressive disorder: a pooled post hoc analysis (studies CN138-139 and CN138-163)
Objective: To evaluate the safety and tolerability of aripiprazole adjunctive to standard
antidepressant therapy (ADT) for patients with major depressive disorder (DSM-IV-TR …
antidepressant therapy (ADT) for patients with major depressive disorder (DSM-IV-TR …
[HTML][HTML] Combinación de antidepresivos vs. aumentación con antipsicóticos atípicos tras no lograr la remisión en la depresión unipolar
R Philippi, R Correa - Revista chilena de neuro-psiquiatría, 2022 - SciELO Chile
Introducción: Lograr la recuperación funcional lo más rápido posible en el tratamiento de la
depresión unipolar es un reto que la práctica clínica debe tratar de afrontar en la actualidad …
depresión unipolar es un reto que la práctica clínica debe tratar de afrontar en la actualidad …
Treatment of recurrent depression
GA Fava, SK Park, N Sonino - Expert Review of Neurotherapeutics, 2006 - Taylor & Francis
Approximately eight out of ten people experiencing a major depressive episode will have
one or more further episodes during their lifetime: a recurrent major depressive disorder …
one or more further episodes during their lifetime: a recurrent major depressive disorder …
Difference in the regulation of biological rhythm symptoms of Major depressive disorder between escitalopram and mirtazapine
H Huang, F Wang, Y Chen, S Kong, Q Huang… - Journal of Affective …, 2022 - Elsevier
Background Biological rhythm plays an important role in major depressive disorder (MDD).
The efficacy of antidepressant in biological rhythm remains unclear. This study is designed …
The efficacy of antidepressant in biological rhythm remains unclear. This study is designed …
Pre-treatment insomnia as a predictor of single and combination antidepressant outcomes: a CO-MED report
SC Sung, SR Wisniewski, JF Luther, MH Trivedi… - Journal of affective …, 2015 - Elsevier
Background Most patients with major depressive disorder (MDD) report clinically significant
sleep problems. Pre-treatment insomnia has been associated with poorer treatment …
sleep problems. Pre-treatment insomnia has been associated with poorer treatment …
Major depressive disorder: the South African Society of psychiatrists (SASOP) treatment guidelines for psychiatric disorders
G Grobler - South African Journal of Psychiatry, 2013 - journals.co.za
This treatment guideline draws on several international guidelines:(i) Practice Guidelines of
the American Psychiatric Association (APA) for the Treatment of Patients with Major …
the American Psychiatric Association (APA) for the Treatment of Patients with Major …
Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L …
BACKGROUND: Antidepressant monotherapy is effective in achieving treatment remission
in only approximately one third of patients with depression, and even switching to a second …
in only approximately one third of patients with depression, and even switching to a second …
Augmenting antidepressants with folate: a clinical perspective
M Fava - JOURNAL OF CLINICAL PSYCHIATRY, 2007 - psychiatrist.com
The goal of treatment of depression is full remission, but only a minority of patients will
achieve full remission with antidepressant monotherapy. Several forms of augmentation …
achieve full remission with antidepressant monotherapy. Several forms of augmentation …